(Q38037118)

English

Rationale for the clinical application of flow cytometry in patients with myelodysplastic syndromes: position paper of an International Consortium and the European LeukemiaNet Working Group

scientific article published on 14 September 2012

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

27 August 2017

Rationale for the clinical application of flow cytometry in patients with myelodysplastic syndromes: position paper of an International Consortium and the European LeukemiaNet Working Group (English)

1 reference

Europe PubMed Central

PubMed publication ID

27 August 2017

1 reference

based on heuristic

inferred from title

Eva Hellström-Lindberg

21

object named as

Eva Hellström-Lindberg

0 references

16

object named as

Jean Feuillard

1 reference

Europe PubMed Central

PubMed publication ID

27 August 2017

17

object named as

Pierre Fenaux

1 reference

Europe PubMed Central

PubMed publication ID

27 August 2017

19

object named as

Ulrich Germing

1 reference

Europe PubMed Central

PubMed publication ID

27 August 2017

Uwe Platzbecker

37

object named as

Uwe Platzbecker

1 reference

Europe PubMed Central

PubMed publication ID

27 August 2017

34

object named as

Alberto Orfao

1 reference

Europe PubMed Central

PubMed publication ID

27 August 2017

Vincent H J van der Velden

46

object named as

Vincent H J van der Velden

1 reference

Europe PubMed Central

PubMed publication ID

27 August 2017

Jeroen G Te Marvelde

26

object named as

Jeroen G te Marvelde

1 reference

Europe PubMed Central

PubMed publication ID

27 August 2017

Arjan A van de Loosdrecht

1

object named as

Arjan A van de Loosdrecht

1 reference

Europe PubMed Central

PubMed publication ID

27 August 2017

Frank W M B Preijers

38

object named as

Frank Preijers

1 reference

Europe PubMed Central

PubMed publication ID

27 August 2017

author name string

Robin Ireland

2

1 reference

Europe PubMed Central

PubMed publication ID

27 August 2017

Wolfgang Kern

3

1 reference

Europe PubMed Central

PubMed publication ID

27 August 2017

Matteo G Della Porta

4

1 reference

Europe PubMed Central

PubMed publication ID

27 August 2017

Canan Alhan

5

1 reference

Europe PubMed Central

PubMed publication ID

27 August 2017

Jan Sebastian Balleisen

6

1 reference

Europe PubMed Central

PubMed publication ID

27 August 2017

Peter Bettelheim

7

1 reference

Europe PubMed Central

PubMed publication ID

27 August 2017

David T Bowen

8

1 reference

Europe PubMed Central

PubMed publication ID

27 August 2017

Kate Burbury

9

1 reference

Europe PubMed Central

PubMed publication ID

27 August 2017

Lisa Eidenschink

10

1 reference

Europe PubMed Central

PubMed publication ID

27 August 2017

Mario Cazzola

11

1 reference

Europe PubMed Central

PubMed publication ID

27 August 2017

Spencer S C Chu

12

1 reference

Europe PubMed Central

PubMed publication ID

27 August 2017

Matthew Cullen

13

1 reference

Europe PubMed Central

PubMed publication ID

27 August 2017

Jevon A Cutler

14

1 reference

Europe PubMed Central

PubMed publication ID

27 August 2017

Angelika M Dräger

15

1 reference

Europe PubMed Central

PubMed publication ID

27 August 2017

Patricia Font

18

1 reference

Europe PubMed Central

PubMed publication ID

27 August 2017

Detlef Haase

20

1 reference

Europe PubMed Central

PubMed publication ID

27 August 2017

Eva Hellström-Lindberg

21

1 reference

Europe PubMed Central

PubMed publication ID

27 August 2017

Ulrika Johansson

22

1 reference

Europe PubMed Central

PubMed publication ID

27 August 2017

Shahram Kordasti

23

1 reference

Europe PubMed Central

PubMed publication ID

27 August 2017

Michael R Loken

24

1 reference

Europe PubMed Central

PubMed publication ID

27 August 2017

Luca Malcovati

25

1 reference

Europe PubMed Central

PubMed publication ID

27 August 2017

Sergio Matarraz

27

1 reference

Europe PubMed Central

PubMed publication ID

27 August 2017

Timothy Milne

28

1 reference

Europe PubMed Central

PubMed publication ID

27 August 2017

Bijan Moshaver

29

1 reference

Europe PubMed Central

PubMed publication ID

27 August 2017

Ghulam J Mufti

30

1 reference

Europe PubMed Central

PubMed publication ID

27 August 2017

Veselka Nikolova

31

1 reference

Europe PubMed Central

PubMed publication ID

27 August 2017

Kiyoyuki Ogata

32

1 reference

Europe PubMed Central

PubMed publication ID

27 August 2017

Uta Oelschlaegel

33

1 reference

Europe PubMed Central

PubMed publication ID

27 August 2017

Gert J Ossenkoppele

35

1 reference

Europe PubMed Central

PubMed publication ID

27 August 2017

Anna Porwit

36

1 reference

Europe PubMed Central

PubMed publication ID

27 August 2017

Katherina Psarra

39

1 reference

Europe PubMed Central

PubMed publication ID

27 August 2017

Stephen J Richards

40

1 reference

Europe PubMed Central

PubMed publication ID

27 August 2017

Dolores Subirá

41

1 reference

Europe PubMed Central

PubMed publication ID

27 August 2017

John F Seymour

42

1 reference

Europe PubMed Central

PubMed publication ID

27 August 2017

Vicky Tindell

43

1 reference

Europe PubMed Central

PubMed publication ID

27 August 2017

Teresa Vallespi

44

1 reference

Europe PubMed Central

PubMed publication ID

27 August 2017

Peter Valent

45

1 reference

Europe PubMed Central

PubMed publication ID

27 August 2017

Denise A Wells

47

1 reference

Europe PubMed Central

PubMed publication ID

27 August 2017

Theo M de Witte

48

1 reference

Europe PubMed Central

PubMed publication ID

27 August 2017

Florian Zettl

49

1 reference

Europe PubMed Central

PubMed publication ID

27 August 2017

Marie C Béné

50

1 reference

Europe PubMed Central

PubMed publication ID

27 August 2017

Theresia M Westers

51

1 reference

Europe PubMed Central

PubMed publication ID

27 August 2017

publication date

14 September 2012

1 reference

Europe PubMed Central

PubMed publication ID

27 August 2017

Leukemia & Lymphoma

1 reference

Europe PubMed Central

PubMed publication ID

27 August 2017

54

1 reference

Europe PubMed Central

PubMed publication ID

27 August 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

27 August 2017

472-475

1 reference

Europe PubMed Central

PubMed publication ID

27 August 2017

Definitions and standards in the diagnosis and treatment of the myelodysplastic syndromes: Consensus statements and report from a working conference

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2012.718341

21 January 2018

Standardization of flow cytometry in myelodysplastic syndromes: report from the first European LeukemiaNet working conference on flow cytometry in myelodysplastic syndromes

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2012.718341

21 January 2018

The World Health Organization (WHO) classification of the myeloid neoplasms

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2012.718341

21 January 2018

Prognostic factors and life expectancy in myelodysplastic syndromes classified according to WHO criteria: a basis for clinical decision making.

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2012.718341

21 January 2018

Identification of distinct prognostic subgroups in low- and intermediate-1-risk myelodysplastic syndromes by flow cytometry

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2012.718341

21 January 2018

Flow cytometric analysis of myelomonocytic cells by a pattern recognition approach is sensitive and specific in diagnosing myelodysplastic syndrome and related marrow diseases: emphasis on a global evaluation and recognition of diagnostic pitfalls

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2012.718341

21 January 2018

Idiopathic cytopenia of undetermined significance (ICUS) versus low risk MDS: the diagnostic interface.

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2012.718341

21 January 2018

Minimal diagnostic criteria for myelodysplastic syndromes and separation from ICUS and IDUS: update and open questions

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2012.718341

21 January 2018

Diagnostic utility of flow cytometry in low-grade myelodysplastic syndromes: a prospective validation study

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2012.718341

21 January 2018

Multicenter validation of a reproducible flow cytometric score for the diagnosis of low-grade myelodysplastic syndromes: results of a European LeukemiaNET study

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2012.718341

21 January 2018

Myeloid and monocytic dyspoiesis as determined by flow cytometric scoring in myelodysplastic syndrome correlates with the IPSS and with outcome after hematopoietic stem cell transplantation

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2012.718341

21 January 2018

Diagnostic application of flow cytometric characteristics of CD34+ cells in low-grade myelodysplastic syndromes.

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2012.718341

21 January 2018

Validation of a flow cytometric scoring system as a prognostic indicator for posttransplantation outcome in patients with myelodysplastic syndrome

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2012.718341

21 January 2018

The immunophenotype of different immature, myeloid and B-cell lineage-committed CD34+ hematopoietic cells allows discrimination between normal/reactive and myelodysplastic syndrome precursors.

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2012.718341

21 January 2018

New comprehensive cytogenetic scoring system for primary myelodysplastic syndromes (MDS) and oligoblastic acute myeloid leukemia after MDS derived from an international database merge

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2012.718341

21 January 2018

Refinement of the international prognostic scoring system (IPSS) by including LDH as an additional prognostic variable to improve risk assessment in patients with primary myelodysplastic syndromes (MDS).

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2012.718341

21 January 2018

Acquired mutations in TET2 are common in myelodysplastic syndromes

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2012.718341

21 January 2018

Somatic mutations of the histone methyltransferase gene EZH2 in myelodysplastic syndromes

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2012.718341

21 January 2018

Risk stratification based on both disease status and extra-hematologic comorbidities in patients with myelodysplastic syndrome

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2012.718341

21 January 2018

Coalesced multicentric analysis of 2,351 patients with myelodysplastic syndromes indicates an underestimation of poor-risk cytogenetics of myelodysplastic syndromes in the international prognostic scoring system

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2012.718341

21 January 2018

Frequent pathway mutations of splicing machinery in myelodysplasia

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2012.718341

21 January 2018

Clinical effect of point mutations in myelodysplastic syndromes

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2012.718341

21 January 2018

Clinical significance of SF3B1 mutations in myelodysplastic syndromes and myelodysplastic/myeloproliferative neoplasms

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2012.718341

21 January 2018

Phenotypic abnormalities strongly reflect genotype in patients with unexplained cytopenias.

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2012.718341

21 January 2018

Clinical utility of multiparameter flow cytometry in the diagnosis of 1013 patients with suspected myelodysplastic syndrome: correlation to cytomorphology, cytogenetics, and clinical data

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2012.718341

21 January 2018

CD4+CD25high Foxp3+ regulatory T cells in myelodysplastic syndrome (MDS).

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2012.718341

21 January 2018

Reduced natural killer (NK) function associated with high-risk myelodysplastic syndrome (MDS) and reduced expression of activating NK receptors

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2012.718341

21 January 2018

Immune mediated autologous cytotoxicity against hematopoietic precursor cells in patients with myelodysplastic syndrome

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2012.718341

21 January 2018

IL-17-producing CD4(+) T cells, pro-inflammatory cytokines and apoptosis are increased in low risk myelodysplastic syndrome.

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2012.718341

21 January 2018

p-ERK1/2 is a predictive factor of response to erythropoiesis-stimulating agents in low/int-1 myelodysplastic syndromes.

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2012.718341

21 January 2018

Continued azacitidine therapy beyond time of first response improves quality of response in patients with higher-risk myelodysplastic syndromes

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2012.718341

21 January 2018

Identifiers

10.3109/10428194.2012.718341

1 reference

Europe PubMed Central

PubMed publication ID

27 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

27 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38037118&oldid=2151266775"